When AI Gets Your Drug Wrong: The Hidden Risk of Outdated Training Data in Pharma AI Responses
In March 2023, the FDA updated the prescribing information for Dupixent (dupilumab) to include new warnings around eosinophilic conditions. Physicians […]
General
When AI Gets Clinical Trials Wrong: What Pharma Brand Teams Must Monitor Now
A physician in Cincinnati asks ChatGPT whether semaglutide reduces cardiovascular events in patients without diabetes. The AI answers confidently, citing
Pharma Brand Protection in the Age of AI: Monitor LLMs Before They Monitor You
Every day, millions of patients type questions about their prescriptions into ChatGPT, Perplexity, Gemini, and Claude. They ask whether Ozempic
When AI Gives Contradictory Drug Advice: The Pharma Brand Risk No One Is Measuring
Ask ChatGPT whether Ozempic is safe for patients with a history of pancreatitis. Then ask Gemini. Then ask Perplexity. You
AI Search Visibility Is Now a Pharma KPI: How Drug Brands Monitor, Measure, and Win in the LLM Era
For twenty years, pharmaceutical brand teams had a reliable map of how patients found their drugs. A television ad for
FDA Labels Are No Longer Enough: How AI Search Is Rewriting the Drug Information Layer
For decades, the FDA-approved prescribing information label was the pharmaceutical industry’s single source of truth. Physicians consulted it. Pharmacists cited
AI Competitive Intelligence for Pharma: What ChatGPT, Gemini, and Perplexity Say About Your Drug
Pharmaceutical competitive intelligence used to mean analysts scraping clinical trial registries, reading SEC filings at midnight, and counting booth traffic
AI Is Manufacturing Drug Word-of-Mouth — and Most Pharma Companies Aren’t Watching
When a patient asks ChatGPT whether they should switch from Ozempic to Wegovy, the model answers. When a caregiver types
Medical Affairs Teams: Test AI Weekly or Lose Control of Your Drug’s Narrative
A physician types a patient’s medication into ChatGPT at 11 p.m. asking whether it interacts with metformin. The AI answers
Build a Pharma AI Monitoring Program: Track LLM Drug Mentions Before the FDA Does
When a patient types ‘What’s the best GLP-1 drug for weight loss?’ into ChatGPT, the answer they receive is not
The Hidden Operational Risk of Unmonitored AI Drug Content
Somewhere right now, a patient is asking ChatGPT whether they can take metformin with their new blood pressure medication. A
Move First or Get Left Behind: Why Pharma Needs an AI Search Strategy Now
When a patient types “Is Ozempic safe for long-term use?” into ChatGPT, they get an answer. That answer cites no